What is Otto?
Otto operates as a specialized customer engagement platform designed to streamline the interaction between veterinary practices and pet owners. By integrating communication tools, appointment scheduling, and automated follow-up systems, the company addresses the operational inefficiencies inherent in traditional veterinary care. Its market position is defined by its ability to bridge the gap between clinical service delivery and modern consumer expectations for digital accessibility. As the veterinary industry undergoes a rapid digital transformation, Otto provides the essential infrastructure required for clinics to maintain high standards of client retention and operational efficiency. The platform's focus on enhancing the pet-owner experience has made it a vital partner for modern veterinary clinics seeking to optimize their practice management workflows.
How much funding has Otto raised?
Otto has raised a total of $43M across 1 funding round:
Series B
$43M
Series B (2023): $43M with participation from Hill's Pet Nutrition, Mercury Ecommerce Acquisition, and Boehringer Ingelheim
Key Investors in Otto
Hill's Pet Nutrition
Hill's Pet Nutrition is a global leader in science-based pet nutrition, offering specialized dietary solutions for dogs and cats through its extensive product lines. As a subsidiary of Colgate-Palmolive, the firm emphasizes research-driven health outcomes and supports animal welfare initiatives globally.
Mercury Ecommerce Acquisition
Mercury Ecommerce Acquisition Corp is a Houston-based blank check company established to facilitate strategic mergers and business combinations within the ecommerce and technology sectors.
Boehringer Ingelheim
Boehringer Ingelheim is a research-driven pharmaceutical giant with a significant focus on animal health, developing innovative medicines and healthcare products for companion animals and livestock on a global scale.
What's next for Otto?
The recent strategic investment provides Otto with the necessary resources to scale its enterprise-level offerings and potentially explore new market segments within the broader animal health industry. Given the involvement of major pharmaceutical and nutritional stakeholders, the company is likely to prioritize the integration of its engagement platform with broader veterinary health ecosystems. Future growth strategies will likely center on enhancing data-driven insights for clinics, improving the interoperability of its software with existing practice management systems, and potentially expanding its geographic reach. By leveraging the expertise of its strategic backers, Otto is poised to solidify its role as a foundational technology provider in the veterinary sector, driving long-term value through improved clinical outcomes and enhanced client engagement metrics.
See full Otto company page
